ليست عنوان مقالات لاتين Coronary Artery Bypass Graft Patency and Competitive Flow Corporate identity: The role of mission statements

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Coronary Artery Bypass Graft Patency and Competitive Flow

2

Coronary artery bypass graft surgery after thrombolytic therapy in the thrombolysis in myocardial infarction trial, Phase II (TIMI II)

3

Coronary artery bypass graft surgery in patients with recent exposure to clopidogrel and aspirin therapy

4

Coronary artery bypass graft surgery outcomes following 6.5 years: A nested case–control study

5

Coronary artery bypass graft surgery patients and their family member caregivers: Outcomes of a family-focused staged psychoeducational intervention

6

Coronary Artery Bypass Grafting (CABG) Without General Anaesthesia- An Initial Experience in NICVD, Dhaka, Bangladesh

7

Coronary artery bypass grafting “On Pump”: role of three-day discharge

8

Coronary Artery Bypass Grafting After a Bilateral Lung Volume Reduction Operation

9

Coronary Artery Bypass Grafting After Previous Stenting is Associated With Compromised Long-Term Efficacy

10

Coronary Artery Bypass Grafting Baseline Cognitive Assessment: Essential Not Optional

11

Coronary Artery Bypass Grafting Combined with Total Occlusion of Internal Carotid Artery

12

Coronary artery bypass grafting in a patient with antiphospholipid syndrome

13

Coronary artery bypass grafting in a patient with total occlusion of both internal carotid arteries

14

Coronary artery bypass grafting in adult coronary artery disease due to suspected Kawasaki disease in childhood

15

Coronary Artery Bypass Grafting in advance aged patients

16

Coronary artery bypass grafting in an immune thrombocytopenic purpura patient using off-pump techniques

17

Coronary artery bypass grafting in dialysis patients

18

Coronary Artery Bypass Grafting In Familial Hypercholesterolemia

19

Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura

20

Coronary artery bypass grafting in patients after failure of intracoronary stenting

21

Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients

22

Coronary artery bypass grafting in patients who require long-term dialysis

23

Coronary artery bypass grafting in patients with advanced left ventricular dysfunction

24

Coronary Artery Bypass Grafting in Patients with Advanced Left Ventricular Dysfunction: Excellent Early Outcome with Improved Ejection Fraction

25

Coronary artery bypass grafting in patients with cerebrovascular disease Review Article

26

Coronary artery bypass grafting in the elderly

27

Coronary artery bypass grafting in type II diabetic patients: a comparison between insulin-dependent and non-insulin-dependent patients at short- and mid-term follow-up

28

Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study

29

Coronary Artery Bypass Grafting is Still the Best Treatment for Multivessel and Left Main Disease, But Patients Need to Know

30

Coronary Artery Bypass Grafting is Superior to Percutaneous Coronary Intervention in Prevention of Perioperative Myocardial Infarctions During Subsequent Vascular Surgery

31

Coronary artery bypass grafting on the beating heart: a simple technique for subluxating the heart

32

Coronary Artery Bypass Grafting Using an Abdominal Artery as an Inflow

33

Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients

34

Coronary artery bypass grafting using the radial artery: midterm results in a Japanese institute

35

Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy

36

Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation for Left Main Coronary Artery Disease (from a Two-Center Registry)

37

Coronary artery bypass grafting with an expanded polytetrafluoroethylene graft

38

Coronary artery bypass grafting with cardiopulmonary bypass versus off-pump cardiopulmonary bypass grafting: does eliminating the pump reduce morbidity and cost?

39

Coronary artery bypass grafting with gastroepiploic artery composite graft

40

Coronary artery bypass grafting with left internal mammary artery and right gastroepiploic artery, with and without bypass

41

Coronary Artery Bypass Grafting With Single Cross-Clamp Results in Fewer Persistent Neuropsychological Deficits Than Multiple Clamp or Off-Pump Coronary Artery Bypass Grafting

42

Coronary artery bypass grafting within 30 days of an acute myocardial infarction

43

Coronary artery bypass grafting without cardiopulmonary bypass

44

Coronary artery bypass grafting without cardiopulmonary bypass

45

Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using novel anastomosis site restraining device (“Octopus”)

46

Coronary artery bypass grafting without cardiopulmonary bypass through sternotomy and minimally invasive procedure

47

Coronary Artery Bypass Grafting: A Precipitating Factor for Perioperative Diabetic Ketoacidosis

48

Coronary Artery Bypass Grafting: Long-Term Psychological and Social Outcomes

49

Coronary artery bypass in patients 80 years and over: is off-pump the operation of choice?

50

Coronary Artery Bypass is Superior to Drug-Eluting Stents in Multivessel Coronary Artery Disease

51

Coronary artery bypass operation after pneumonectomy

52

Coronary Artery Bypass Risk Prediction Using Neural Networks

53

Coronary Artery Bypass Surgery and Acute Kidney Injury: Impact of the Off-Pump Technique

54

Coronary artery bypass surgery by the transdiaphragmatic approach

55

Coronary Artery Bypass Surgery in Coronary Artery Disease Concomitant with Porcelain Aorta: Great Challenge for Cardiac surgeon

56

Coronary artery bypass surgery in octogenarians: outcomes in a tertiary referral university hospital in a developing country

57

Coronary artery bypass surgery in patients with severe left ventricular dysfunction

58

Coronary artery bypass surgery is still cost-effective: using calibrated models toupdate clinical trials

59

Coronary artery bypass surgery or percutaneous coronary intervention after fibrinolysis: A critical reappraisal

60

Coronary Artery Bypass Surgery versus Medical Treatment in Patients with Low Ejection Fraction and Coronary Artery Disease

61

Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial

62

Coronary artery bypass surgery: Why donʹt the wealthy choose the best hospitals?

63

Coronary artery bypass via diaphragmatic approach with free graft

64

Coronary artery bypass: a userʹs manual

65

Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach

66

Coronary Artery Calcification and Changes in Atheroma Burden in Response to Established Medical Therapies Original Research Article

67

Coronary Artery Calcification and Myocardial Perfusion in Asymptomatic Adults: The MESA (Multi-Ethnic Study of Atherosclerosis) Original Research Article

68

Coronary Artery Calcification and Myocardial Perfusion: Kissing Cousins or Distant Relatives?

69

Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism

70

Coronary artery calcification in black women and white women

71

Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study

72

Coronary artery calcification on computed tomography

73

Coronary artery calcification on computed tomography

74

Coronary artery calcification on computed tomography

75

Coronary artery calcification on computed tomography

76

Coronary artery calcification screening to rule out acute myocardial infarction prior to hospital admission

77

Coronary Artery Calcification, an Improvement in Risk Classification: Need for Reappraisal?

78

Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1 treated with protease inhibitors

79

Coronary artery calcification: “...empty your cup...”, ,

80

Coronary Artery Calcification: Pathogenesis and Prognostic Implications

81

Coronary artery calcifications in the long-term follow-up of Kawasaki disease

82

Coronary artery calcium (CAC) score – a prognostic tool in coronary artery disease

83

Coronary Artery Calcium and Risk of Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis)

84

Coronary artery calcium as a measure of biologic age

85

Coronary Artery Calcium Detected by Digital Fluoroscopy and Risk Factors in Healthy Subjects

86

Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events

87

Coronary Artery Calcium Progression: An Important Clinical Measurement?: A Review of Published Reports

88

Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment

89

Coronary Artery Calcium Score Assessment in Breast Cancer Patients After Three-Dimensional Conformal Radiotherapy: Is Calcium Score an Appropriate Screening Study?

90

Coronary artery calcium score, risk factors, and incident coronary heart disease events

91

Coronary Artery Calcium Score: A Review

92

Coronary Artery Calcium to Predict All-Cause Mortality in Elderly Men and Women Original Research Article

93

Coronary Artery Calcium Versus Intima-Media Thickness as a Measure of Cardiovascular Disease Among Asymptomatic Adults (from The Rancho Bernardo Study)

94

Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults

95

Coronary Artery Calcium, Carotid Artery Wall Thickness, and Cardiovascular Disease Outcomes in Adults 70 to 99 Years Old

96

Coronary artery calcium, exercise tolerance, and CHD events in asymptomatic men

97

Coronary Artery Complications in Infective Endocarditis

98

Coronary Artery Diameter as a Risk Factor for Acute Coronary Syndromes in Asian-Indians

99

Coronary Artery Diameters in Infants and Children With Congenital Heart Disease as Determined by Computed Tomography

100

Coronary artery dimensions in primary and secondary left ventricular hypertrophy

101

Coronary artery disease after heart transplantation and its relation to cytomegalovirus

102

Coronary Artery Disease and High Altitude: Unresolved Issues

103

Coronary Artery Disease and Its Risk Factors Status in Iran: A Review

104

Coronary artery disease and opioid use

105

Coronary artery disease and plasma apolipoprotein E4 in mild cognitive impairment

106

Coronary Artery Disease in critical patients of Iran

107

Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease: A report from the Coronary Artery Surgery Study Registry, ,

108

Coronary artery disease in diabetic patients: A major therapeutic challenge

109

Coronary artery disease in identical twins

110

Coronary artery disease in identical twins

111

Coronary artery disease in India: challenges and opportunities

112

Coronary artery disease in Iranian overweight women

113

Coronary Artery Disease in Minority Racial and Ethnic Groups in the United States

114

Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor

115

Coronary artery disease in patients undergoing valve replacement at a tertiary care cardiac centre

116

Coronary Artery Disease in patients with chest pain who have low-risk clinical characteristics and negative cardiac troponin I

117

Coronary artery disease in patients with chronic kidney disease: a brief literature review

118

Coronary artery disease in patients with heart failure and preserved systolic function

119

Coronary artery disease in patients with peripheral artery disease

120

Coronary Artery Disease in Patients With Psoriasis Referred for Coronary Angiography

121

Coronary artery disease in patients with type A aortic dissection

122

Coronary artery disease in the developing world

123

Coronary artery disease in the LDL-Apheresis atherosclerosis regression study (LAARS)

124

Coronary artery disease in young adults

125

Coronary Artery Disease in Young: Faulty Life Style or Heredofamilial or Both

126

Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects

127

Coronary artery disease is more than just coronary lumen disease

128

Coronary Artery Disease Presentation and Its Association with Shortened Activated Partial Thromboplastin Time

129

Coronary Artery Disease Prognosis and C-Reactive Protein Levels Improve in Proportion to Percent Lowering of Low-Density Lipoprotein

130

Coronary artery disease progression assessed by electron-beam computed tomography

131

Coronary Artery Disease Progression Late After Successful Stent Implantation

132

Coronary Artery Disease Risk Factors in an Urban and Peri-urban Setting, Kerman, Southeastern Iran (KERCADR Study): Methodology and Preliminary Report

133

CORONARY ARTERY DISEASE RISK FACTORS IN DRIVERS VERSUS PEOPLE IN OTHER OCCUPATIONS

134

Coronary Artery Disease Risk Factors in Patients Undergoing Coronary Artery Bypass Graft Surgery

135

Coronary Artery Disease: A Review of Risk Factors

136

Coronary artery disease: changes of blood lymphocyte subsets induced by physical exercise

137

Coronary artery disease: the folate link

138

Coronary artery disease: the Scandinavian Simvastatin Survival Study Experience

139

Coronary Artery Diseases in Women

140

Coronary artery dissection

141

Coronary artery dissection after blunt chest trauma: Depiction at multidetector-row computed tomography

142

Coronary artery dissection following angioplasty detected by multi-detector row computed tomography: Evaluation using the Plaque Map system

143

Coronary Artery Dissection in a Woman With Previous Systemic Lupus Erythematosus Using Oral Contraceptive Pills

144

Coronary Artery Distensibility Assessed by 3.0 Tesla Coronary Magnetic Resonance Imaging in Subjects With and Without Coronary Artery Disease

145

Coronary artery distensibility in diabetic patients with simultaneous measurements of luminal are and intracoronary pressure : Evidence of impaired reactivity to nitroglycerin

146

Coronary Artery Dominance: What pattern exists in Pakistani Population?

147

Coronary Artery Ectasia in a Patient with Polycystic Kidney Disease

148

Coronary artery ectasia is associated with atrial electrical and mechanical dysfunction: an observational study

149

Coronary Artery Ectasia is Associated with the Elevation of Mean Platelet Volume Regardless of an Existing Acute Coronary Syndrome

150

Coronary Artery Ectasia Presenting as a Non-ST Elevation Myocardial Infarction in a Young Adult: Case Presentation and Literature Review

151

Coronary Artery Ectasia, its Clinical Profile and Angiographic Characteristics, Single Centre Experience

152

Coronary artery ectasia: Is it a destructive inflammatory lesion of the vascular wall?

153

Coronary artery endarterectomy for retrieval of entrapped percutaneous angioplasty catheter

154

Coronary artery endothelial function after myocardial ischemia and reperfusion

155

Coronary artery endothelial protection after local delivery of 17β-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function

156

Coronary Artery Erosion and Dissection: An Unusual Complication of Mitral Annular Calcification

157

Coronary Artery Fistula

158

Coronary Artery Fistula and Pectus Excavatum Paradox

159

Coronary Artery Fistula as a Bypass of a Left Anterior Descending Coronary Artery Stenosis

160

Coronary Artery Fistula Diagnosed by Echocardiography during NSTEMI: Case Report and Review of Literature

161

Coronary artery fistula draining into the pulmonary artery

162

Coronary Artery Fistula from Left Circumflex to Coronary

163

Coronary artery fistula in children and adults: a review of 25 cases with long-term observations

164

Coronary artery fistula presented as infective endocarditis with pulmonary septic emboli

165

Coronary Artery Fistula with Double Outlet Right Ventricle: a Case Report

166

Coronary Artery Fistula with Double Outlet Right Ventricle: a Case Report

167

Coronary artery fistula: multidetector row computed tomography angiography in young child

168

Coronary artery fistulae from single coronary artery in a patient with rheumatic mitral stenosis

169

Coronary artery fistulas in infants and children: A surgical review and discussion of coil embolization

170

Coronary artery fistulas presenting with bacterial endocarditis

171

Coronary artery fistulas: Clinical and therapeutic considerations

172

Coronary artery fistulas: long-term results of surgical correction

173

Coronary artery flow measurement using navigator echo gated phase contrast magnetic resonance velocity mapping at 3.0 T

174

Coronary artery flow measurement with magnetic resonance imaging: validation with ultrasound

175

Coronary artery flow ten weeks after myocardial infarction or unstable angina: effects of combined warfarin and aspirin therapy

176

Coronary Artery Hematoma Treated with Fenestration Using a Novel NSE AlphaD Scoring Balloon

177

Coronary artery imaging with multidetector computed tomography: A call for an evidence-based, multidisciplinary approach

178

Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization

179

Coronary artery intimal hyperplasia, occlusive platelet thrombus, and fatal myocardial infarction in an intravenous cocaine user

180

Coronary artery involvement early and late after radiofrequency current application in young pigs, , ,

181

Coronary Artery Involvement Kawasaki Disease Versus Non-Kawasaki Febrile Diseases in Children Attending a Pediatric Hospital in Bandar Abbas

182

Coronary Artery Manifestations of Fibromuscular Dysplasia

183

Coronary artery morphologic features after coronary rotational atherectomy: Insights into mechanisms of lumen enlargement and embolization

184

Coronary artery narrowing after aortic root reconstruction with resorcin-formalin glue

185

Coronary Artery Obstruction After the Arterial Switch Operation for Transposition of the Great Arteries in Newborns

186

Coronary artery obstruction caused by perivalvular abscess in aortic valve endocarditis

187

Coronary artery obstruction due to membranous ridge of the right sinus valsalva associated with Tetralogy of Fallot: syncope mimics anoxic spell

188

Coronary artery operation in patients after breast cancer therapy

189

Coronary Artery Origin Anomalies with Especial Emphasis on Delayed Diagnosis of Anomalous Origin of the Left Coronary Artery from Pulmonary Artery, A report from South of Iran

190

Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the hurler syndrome

191

Coronary Artery Perforation after Guidewire Removal

192

Coronary artery problems during homograft aortic valve replacement: role of transesophageal echocardiography

193

Coronary artery reconstruction for extensive coronary disease: 108 patients and two year follow-up

194

Coronary Artery Reconstruction: Optimal Technique of Coronary Endarterectomy

195

Coronary artery reoperation through the left thoracotomy with hypothermic circulatory arrest

196

Coronary artery response to cold-pressor test is impaired early after operation in heart transplant recipients

197

Coronary artery restenosis after atherectomy is primarily due to negative remodeling

198

Coronary Artery Revascularization (CARE) Registry: An Observational Study of On-Pump and Off-Pump Coronary Artery Revascularization

199

Coronary Artery Revascularization After Chest Wall Reconstruction With Rectus Abdominis Myocutaneous Flap

200

Coronary Artery Revascularization in a young adult with Solitary Coronary Aneurysm probably secondary to childhood Kawasaki Disease

201

Coronary Artery Revascularization in a Young Adult with Solitary Coronary Aneurysm ProbablySecondary to Childhood Kawasaki Disease

202

Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction

203

Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome

204

Coronary artery spasm and ventricular fibrillation after off-pump coronary surgery Coronary artery spasm and ventricular fibrillation after off-pump coronary surgery

205

Coronary Artery Spasm as a Frequent Cause of Acute Coronary Syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study Original Research Article

206

Coronary Artery Spasm During Dobutamine Stress Echocardiography: A Case Report

207

Coronary Artery Spasm: A Rare But Important Cause of Postoperative Myocardial Infarction

208

Coronary Artery Spatial Distribution, Morphology, and Composition of Nonculprit Coronary Plaques by 64-Slice Computed Tomographic Angiography in Patients With Acute Myocardial Infarction

209

Coronary artery stenoses: A phantom study using contrast enhanced three-dimensional electron beam tomography

210

Coronary artery stenosis morphology and degree of vasomotion in patients with Prinzmetalʹs variant angin

211

Coronary artery stent mimicking intracardiac thrombus on cardiac magnetic resonance imaging due to signal loss: case report

212

Coronary artery stent outcomes in a Medicare population: Less emergency bypass surgery and lower mortality rates in patients with stents, , ,

213

Coronary artery stent placement as a treatment of acute coronary syndrome in course of variant angina

214

Coronary artery stent placement in patients with variant angina refractory to medical treatment

215

Coronary artery stent restenosis responds favorably to repeat interventions

216

Coronary artery stenting in a patient with angina pectoris caused by coronary artery dissection after blunt chest trauma

217

Coronary artery stenting in cardiac allograft vascular disease

218

Coronary artery stenting in the aged

219

Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up

220

Coronary artery stents

221

Coronary Artery Surgery

222

Coronary artery surgery is associated with different forms of atherogenic lipoprotein modifications

223

Coronary artery to the left atrial fistula after resection of atrial appendages

224

Coronary artery-left ventricular micro-fistulas associated with apical hypertrophic cardiomyopathy

225

Coronary artery-to-left ventricular fistula

226

Coronary atherectomy and thrombectomy

227

Coronary Atheroma Regression and Plaque Characteristics Assessed by Grayscale and Radiofrequency Intravascular Ultrasound After Aerobic Exercise

228

Coronary atherosclerosis and body iron stores

229

Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols

230

Coronary Atherosclerosis and Quantitative Myocardial Perfusion: A Relationship Beyond Stenosis

231

Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study

232

Coronary atherosclerosis in unheralded sudden coronary death under age 50: histo-pathologic comparison with ‘healthy’ subjects dying out of hospital

233

Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose Tissue

234

Coronary atherosclerosis stabilization: an achievable goal Original Research Article

235

Coronary Atherosclerosis: Adiponectin and Leptin as Predictors of Disease Severity

236

Coronary atherosclerosis: is the process focal or diffuse among patients with symptomatic or fatal myocardial ischemia?

237

Coronary atherosclerotic lesions in human immunodeficiency virus–infected patients: a histopathologic study

238

Coronary Bifurcation Lesions Treated With Simple Approach (from the Cordoba & Las Palmas [CORPAL] Kiss Trial)

239

Coronary blood flow during reperfusion as an index of the extend of microvascular damage: Experimental study

240

Coronary blood flow dynamics during transcutaneous electrical nerve stimulation for stable angina pectoris associated with severe narrowing of one major coronary artery

241

Coronary Blood Flow in Patients With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Implantation

242

Coronary blood flow reserve in acute aortic regurgitation

243

Coronary blood flow velocity during apical versus septal pacing

244

Coronary blood flow velocity in normal infants and young adults assessed by transthoracic echocardiography

245

Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis

246

Coronary bypass flow during use of intraaortic balloon pumping and left ventricular assist device

247

Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years

248

Coronary bypass grafting via minithoracotomy on the beating heart

249

Coronary Bypass Grafting Without Use of Cardiopulmonary Bypass for Dextrocardia

250

Coronary Bypass in Women

251

Coronary bypass surgery in women: a long-term comparative study of quality of life after bilateral internal mammary artery grafting in men and women

252

Coronary Calcification and Coronary Artery Disease

253

Coronary calcification and coronary atherosclerosis in asymptomatic persons

254

Coronary Calcification and Coronary Atherosclerosis: Site by Site Comparative Morphologic Study of Electron Beam Computed Tomography and Coronary Angiography

255

Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods

256

Coronary calcification could predict risk of stroke

257

Coronary calcification is more predictive of carotid intimal medial thickness in black compared to white middle aged men

258

Coronary calcification mimicking the stent: Analysis by MDCT Plaque Map

259

Coronary calcification score and predicted risk of coronary heart disease

260

Coronary calcification score: the coronary-risk impact factor

261

Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events: The St. Francis Heart Study Original Research Article

262

Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain

263

Coronary calcium and cardiovascular event risk: Evaluation by age- and sex-specific quartiles

264

Coronary calcium and standard risk factors in symptomatic patients referred for coronary angiography, ,

265

Coronary calcium as a reliable tool for differentiating ischemic from nonischemic cardiomyopathy

266

Coronary calcium as a risk factor: role in global risk assessment

267

Coronary calcium detected by digital cinefluoroscopy and coronary artery disease in patients undergoing coronary arteriography: effects of age and sex

268

Coronary Calcium Independently Predicts Incident Premature Coronary Heart Disease Over Measured Cardiovascular Risk Factors: Mean Three-Year Outcomes in the Prospective Army Coronary Calcium (PACC) Project Original Research Article

269

Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles: MESA (Multi-Ethnic Study of Atherosclerosis)

270

Coronary Calcium Predicts Myocardial Infarction in Asymptomatic Subjects After Two Years of Follow-up

271

Coronary calcium progression rates with a zero initial score by electron beam tomography

272

Coronary Calcium Remains an Effective Filter for Invasive Angiography

273

Coronary calcium scanning adds incremental value to patients with positive stress tests

274

Coronary Calcium Score Improves Classification of Coronary Heart Disease Risk in the Elderly: The Rotterdam Study

275

Coronary Calcium Scoring: Calcium Location Needs to Be Integrated!

276

Coronary calcium: Is racial profiling necessary?

277

Coronary calcium: The good, the bad, and the uncertain, ,

278

Coronary Circulation Responses to Binodenoson, a Selective Adenosine A2A Receptor Agonist

279

Coronary Collateral Circulation: Effect on Early and Midterm Outcomes After Off-Pump Coronary Artery Bypass Surgery

280

Coronary collateral circulation: The effects of smoking and alcohol

281

Coronary collateral development during chronic ischemia: serial assessment using harmonic myocardial contrast echocardiography

282

Coronary Collateral Function Long After Drug-Eluting Stent Implantation Original Research Article

283

Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements

284

Coronary collaterals in patients with normal and impaired left ventricular systolic function

285

Coronary collaterals, stenoses, and stents: Is a new era of physiologic-guided percutaneous revascularization emerging?

286

Coronary collaterals: The role of MCP-1 during the early phase of acute myocardial infarction

287

Coronary collaterals—insights in molecular determinants and prognostic relevance

288

Coronary Collaterals—Too Small to Be Eyeballed, Too Large to Be Meaningless

289

Coronary Complications of Kawasaki Disease: Novel Diagnosis Based on Z-score and Absolute Dimension

290

Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia and Null Allele Low-Density Lipoprotein Receptor Mutations

291

Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Type 2 Diabetes Mellitus

292

Coronary Computed Tomographic Angiographic Findings in Patients With Kawasaki Disease

293

Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical Procedures: Results From the Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry

294

Coronary Computed Tomographic Angiography for Prediction of Procedural and Intermediate Outcome of Bypass Grafting to Left Anterior Descending Artery Occlusion With Failed Visualization on Conventional Angiography

295

Coronary Computed Tomography Angiography After Stress Testing

296

Coronary Computed Tomography Angiography After Stress Testing: Results From a Multicenter, Statewide Registry, ACIC (Advanced Cardiovascular Imaging Consortium)

297

Coronary Computed Tomography Angiography as a Screening Tool for the Detection of Occult Coronary Artery Disease in Asymptomatic Individuals Original Research Article

298

Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain: The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) Trial

299

Coronary computed tomography angiography in a patient with atrial fibrillation, case report

300

Coronary Computed Tomography Angiography in the Emergency Department: The High Stakes Game of Low Risk Chest Pain

301

Coronary Computed Tomography Angiography Versus Coronary Calcium Computed Tomography for Prognosis With Regard to Mortality

302

Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials

303

Coronary Computed Tomography Angiography: CONFIRMations and Perspectives

304

Coronary Computed Tomography Angiography: Is it Time to Replace the Conventional Coronary Angiogram in Heart Transplant Patients?

305

Coronary Computed Tomography Angiography: Our Time Has Come, But There Are Miles to Go Before We Sleep

306

Coronary Computed Tomography Angiography: The Challenge of Coronary Calcium

307

Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients

308

Coronary constriction in constrictive pericarditis

309

Coronary C-reactive protein distribution: its relation to development of atherosclerosis

310

Coronary CT Angiography Again Results in Better Patient Outcomes

311

Coronary CT Angiography and Dual-Energy Computed Tomography in Ischemic Heart Disease Suspected Patients

312

Coronary cyclic flow variations following primary angioplasty is associated with poor short-term prognosis

313

Coronary Diameter and Vasodilator Function in Children Following Arterial Switch Operation for Complete Transposition of the Great Arteries

314

Coronary Dilator Reserve and Morphological Changes After Relief of Pressure-overload in Rats

315

Coronary disease––prone behavior among Japanese men: Job-centered lifestyle and social dominance, ,

316

Coronary dissection and thrombosis after ingestion of ephedra

317

Coronary dominance and prognosis of patients with acute coronary syndrome

318

Coronary Doppler intensity changes during handgrip: new method to detect coronary vasomotor tone in coronary artery disease

319

Coronary drug-eluting stent development: Issues in trial design

320

Coronary echocardiography in tetralogy of Fallot: diagnostic accuracy, resource utilization and surgical implications over 13 years

321

Coronary Ectasia Is Associated with Impaired Left Ventricular Myocardial Performance in Patients without Significant Coronary Artery Stenosis

322

Coronary Emboli in a Young Patient with Mechanical Aortic Valve: A Rare Cause of Acute Myocardial Infarction

323

Coronary Embolism and Myocardial Infarction in a Transgender Male Undergoing Hormone Therapy: A Case Report and Review of the Literature

324

Coronary Embolism and Subsequent Myocardial Abscess Complicating Ventricular Aneurysm and Tachycardia

325

Coronary embolism causing myocardial infarction in a patient with mechanical aortic valve prosthesis

326

Coronary embolism complicating an atrial myxoma

327

Coronary embolism complicating aortic valve endocarditis: Treatment with successful coronary angioplasty

328

Coronary Embolization in Bullet Wounds: Role of Perioperative Coronary Angiography

329

Coronary embolization of a proximal vessel due to retrieval of a balloon catheter with an organized thrombus during primary PCI

330

Coronary embolus secondary to a prosthetic mitral valve and subtherapeutic anticoagulation

331

Coronary endarterectomy and stent removal after iatrogenic perforation

332

Coronary Endarterectomy and Stent Removal in Patients With In-Stent restenosis

333

Coronary endarterectomy with off-pump coronary artery bypass surgery

334

Coronary Endarterectomy: Impact on Morbidity and Mortality When Combined With Coronary Artery Bypass Surgery

335

Coronary Endarterectomy: The Choice of Tactics is Dictated by the Lay of the Land

336

Coronary endothelial dysfunction after Kawasaki disease

337

Coronary Endothelial Dysfunction After Kawasaki Disease: Evaluation by Intracoronary Injection of Acetylcholine

338

Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans

339

Coronary endothelial dysfunction and inflammation of coronary atherosclerosis

340

Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy

341

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

342

Coronary endothelial dysfunction in the early months after heart transplantation

343

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

344

Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid

345

Coronary Endothelial Dysfunction Precedes Heart Failure and Reduction of Coronary Reserve in Awake Dogs

346

Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease

347

Coronary endothelial injury after local occlusion on the human beating heart

348

Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression Original Research Article

349

Coronary endothelium expresses a pathologic gene pattern compared to aortic endothelium: Correlation of asynchronous hemodynamics and pathology in vivo

350

Coronary end-to-side sleeve anastomosis using adhesive in off-pump bypass grafting in the pig

351

Coronary events and coronary care: MONICA project

352

Coronary events and coronary care: MONICA project

353

Coronary events and coronary care: MONICA project

354

Coronary events and coronary care: MONICA project

355

Coronary fistula between the left anterior descending coronary artery and the pulmonary artery: Two case reports

356

Coronary Flow Assessment in Unstable Angina/non ST-segment Elevation Myocardial Infarction Patients via Thrombolysis in Myocardial Infarction Frame Count in Angiography

357

Coronary Flow Dynamics Measured by Computed Tomography Angiography

358

Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries

359

Coronary flow reserve and brachial artery reactivity in patients with chest pain and “false positive” exercise-induced ST-segment depression

360

Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension

361

Coronary Flow Reserve Assessed by Transesophageal Echocardiography Identifies Early Restenosis of the Left Anterior Descending Coronary Artery Angioplasty

362

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

363

Coronary flow reserve assessment by dobutamine transesophageal doppler echocardiography

364

Coronary flow reserve assessment from average peak velocity profiles alone must be judged with caution

365

Coronary Flow Reserve Before and After Coronary Artery Bypass Surgery

366

Coronary flow reserve does not adequately interrogate coronary microvascualr function

367

Coronary Flow Reserve During Coronary Angioplasty in Patients With Recent Myocardial Infarction: Relation to Stenosis and Myocardial Viability

368

Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function

369

Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study

370

Coronary flow reserve in composite arterial Y grafts

371

Coronary Flow Reserve in Hypertensive Patients With Hypercholesterolemia and Without Coronary Heart Disease

372

Coronary Flow Reserve in the Left Anterior Descending Artery Patients, Diagnostic and Prognostic Value of Doppler Echocardiogrphy

373

Coronary flow reserve is also impaired in patients with subclinical hypothyroidism

374

Coronary flow reserve is impaired in patients with aortic valve calcification

375

Coronary flow reserve is impaired in patients with slow coronary flow

376

Coronary Flow Reserve Is Impaired in Young Men With Familial Hypercholesterolemi

377

Coronary flow reserve may predict myocardial recovery after myocardial infarction in patients with TIMI grade 3 flow, ,

378

Coronary flow reserve measurement in the coronary sinus in pre and post CABG status

379

Coronary flow reserve of the angiographically normal left anterior descending coronary artery in patients with remote coronary artery disease

380

Coronary flow reserve or brachial artery flow to assess endothelial dysfunction: is it time to look at the heart again?

381

Coronary Flow Reserve With a Turbo: A Warning for the Use of Adenosine as a Provocative Test in Patients Receiving Ticagrelor?

382

Coronary flow studies for risk stratification in multivessel disease: A physiologic bridge too far?

383

Coronary flow velocity changes after intravenous dipyridamole infusion: Measurements using intravascular Doppler guide wire documentation of flow inhomogeneity

384

Coronary flow velocity immediately after primary coronary stenting as a predictor of ventricular wall motion recovery in acute myocardial infarction

385

Coronary flow velocity reserve and indices describing aortic distensibility in patients after coronary angiography

386

Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention Original Research Article

387

Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease : Results from the pilot phase of the Women’s Ischemi Syndrome Evaluation (WISE) Study

388

Coronary flow, VO2 peak and anaerobic threshold in patients with dilated cardiomyopathy

389

Coronary flow: how far can we go with echocardiography?

390

Coronary Flow: The Holy Grail of Echocardiography?

391

Coronary grafting using a temporary intraluminal shunt instead of heart-lung bypass

392

Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression

393

Coronary heart disease and associated risk factors in Qazvin: a population-based study

394

Coronary heart disease and chlamydia pneumoniae DNA in blood mononuclear cells

395

Coronary heart disease and lipid-modifying treatment in african american patients

396

Coronary heart disease and vitamin E

397

Coronary heart disease deaths and infarctions in people with little or no coronary calcium

398

Coronary heart disease in Chile

399

Coronary heart disease in Indian Asians

400

Coronary heart disease in Indian Asians

401

Coronary Heart Disease in Patients With Diabetes: Part I: Recent Advances in Prevention and Noninvasive Management Review Article

402

Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization Review Article

403

Coronary heart disease in people of south-Asian origin

404

Coronary heart disease in seven countries

405

Coronary heart disease in South Asia: Need to redefine risk

406

Coronary heart disease inequalities: deaths and the socio-economic environment in Nottingham, England

407

Coronary heart disease is a multifactorial disease

408

Coronary heart disease mortality among Arab and Jewish residents of Jerusalem

409

Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates Original Research Article

410

Coronary heart disease mortality and sudden death among the 35–44-year age group in Allegheny County, Pennsylvania

411

Coronary heart disease mortality for six ethnic groups in California, 1990–2000

412

Coronary heart disease mortality, plasma homocysteine, and B-vitamins: a prospective study

413

Coronary heart disease risk factors and menopause: a study in 1684 French women Original Research Article

414

Coronary heart disease risk factors in urban bus drivers

415

Coronary heart disease risk-factor profile in a lower middles class urban community in Pakistan

416

Coronary heart disease still dropping in UK

417

CORONARY HEART DISEASE TOGETHER WITH DIABETES POSES A SERIOUS HEALTH THREAT

418

Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: Meta-analyses of prospective studies, , ,

419

Coronary heart disease, shared care, and cholesterol

420

Coronary heart disease, stroke, and hypertension in a U.S. National cohort: The NHANES I Epidemiologic Follow-up Study

421

Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population

422

Coronary heart disease: Intervention for intimate relationship issues Original Research Article

423

Coronary Heart Disease: Pandemic in a True Sense

424

Coronary heart disease: where have we been and where are we going?

425

Coronary heart disease:: At the interface of molecular genetics and preventive medicine

426

Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon

427

Coronary hemodynamics in patients with symptomatic hypertrophic cardiomyopathy

428

Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty

429

Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up

430

Coronary in-stent restenosis following beta brachytherapy A histopathological examination

431

Coronary in-stent restenosis: Current status and future strategies

432

Coronary Insufficiency After Stentless Aortic Root Replacement: Risk Factors and Solutions

433

Coronary insufficiency in children: Review of literature and report of a rare case with unknown aetiology

434

Coronary intervention at hospitals without on-site cardiac surgery: are we pushing the envelope too far?

435

Coronary Intervention Without a Safety Net

436

Coronary Intervention, Restenosis and Complications

437

Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy

438

Coronary interventions: clinical outcomes and non-stent techniques

439

Coronary interventions: keeping score

440

Coronary intravascular ultrasound: implications for understanding the development and potential regression of atherosclerosis

441

Coronary involvement in Takayasuʹs arteritis

442

Coronary ischemia and percutaneous intervention

443

Coronary ischemia induced Wolf Parkinson White syndrome

444

Coronary ischemic disease, arterial stiffness, and pulse pressure

445

Coronary Ischemic Events after First Atrial Fibrillation: Risk and Survival

446

Coronary lesions at increased risk

447

Coronary lumen at six-month follow-up of a new radiopaque cordis tantalum stent using quantitative angiography and intracoronary ultrasound

448

Coronary Magnetic Resonance Imaging: Coming of Age

449

Coronary malperfusion due to type a aortic dissection: mechanism and surgical management

450

Coronary microcirculation evaluation with transesophageal echocardiography Doppler in type II diabetics

451

Coronary microcirculation: Physiology and mechanics

452

Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina

453

Coronary microembolization

454

Coronary microembolization

455

Coronary Microembolization: the Role of TNF- α in Contractile Dysfunction

456

Coronary microvascular abnormalities in Chagasʹ disease

457

Coronary microvascular dilation is impaired during cold pressor test in diabetic patients with angiographically normal coronary arteries

458

Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure

459

Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study

460

Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox

461

Coronary Microvascular Function and Cortical Pain Processing in Patients With Silent Positive Exercise Testing and Normal Coronary Arteries

462

Coronary microvascular function and myocardial metabolism in patients with dilated cardiomyopathy

463

Coronary microvascular function and myocardial metabolism in the pig model of pacing induced progressive LV dysfunction

464

Coronary Microvascular Reactivity After Ischemic Cold Storage and Reperfusion

465

Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results From the National Heart, Lung and Blood Institute WISE (Womenʹs Ischemia Syndrome Evaluation) Study

466

Coronary microvascular response to intracoronary administration of nicorandil

467

Coronary microvascular spasm and angina pectoris

468

Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina

469

Coronary microvascular spasm in patients with vasospastic angina

470

Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor

471

Coronary morphologic findings after stent implantation

472

Coronary MRI: More Pretty Pictures or Present-Day Value?

473

Coronary Multidetector Computed Tomography: A New Standard for Preoperative Risk Assessment?

474

Coronary Myocardial Bridges: Pathophysiology and Clinical Relevance

475

Coronary narrowing secondary to compression by pericardial hydatid cyst

476

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use

477

Coronary No-reflow Phenomenon: A Review of Therapeutic Pharmacological Agents

478

Coronary obstruction by a calcific pericardial ring

479

Coronary operations in octogenarians: can we select the patients?

480

Coronary operations in patients with spinal cord injury

481

Coronary ostial enlargement to prevent stenosis after prosthetic aortic valve replacement

482

Coronary ostial patch angioplasty in children

483

Coronary ostial reconstruction

484

Coronary Ostial Stenosis After Aortic Valve Replacement, Revisited

485

Coronary perforation during unprotected left main angioplasty. Management with conservative approach: a case report

486

Coronary perforation managed with covered stent

487

Coronary perfusate composition influences diastolic properties, myocardial water content, and histologic characteristics of the rat left ventricle

488

Coronary perfusion methods during off-pump coronary artery bypass: results of a randomized clinical trial

489

Coronary perfusion pressure during cardiopulmonary resuscitation

490

Coronary plague instability in severe acute respiratory syndrome

491

Coronary plaque as a replacement for age as a risk factor in global risk assessment

492

Coronary Plaque Burden and Cardiovascular Risk Factors: Single-Point Versus Serial Assessment

493

Coronary plaque burden detected by multislice computed tomography after acute myocardial infarction with near-normal coronary arteries by angiography

494

Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation

495

Coronary plaque composition, macrophage infiltration and tissue factor content in patients with diabetes mellitus

496

Coronary Plaque Composition: Multifactorial Contribution

497

Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease

498

Coronary plaque morphologic characteristics early and late after heart transplantation: In vivo analysis with intravascular ultrasonography,

499

Coronary plaque regression: role of low density lipoprotein-apheresis

500

Coronary Plaque Rupture and Vessel Remodeling

501

Coronary pseudoaneurysm: An uncommon cause of P.U.O. after a common procedure: An interesting case report

502

Coronary Pseudoaneurysm: An Unreported Complication of Castleman’s Disease

503

Coronary pseudoaneurysms are a known complication of the Bentall wrap-inclusion method of composite valve grafting. We describe two cases to illustrate a straightforward technique for repair and prevention of coronary pseudoaneurysm formation.

504

Coronary pseudo-lesions induced in the left anterior descending and right coronary artery by the angioplasty guide-wire

505

Coronary reactivity to nitroglycerin: Intravascular ultrasound evidence for the importance of plaque distribution

506

Coronary Recanalization by Elective Angioplasty Prevents Ventricular Dilation After Anterior Myocardial Infarction

507

Coronary recanalization in anterior myocardial infarction: The open perforator hypothesis

508

Coronary Reimplantation After Neoaortic Reconstruction Can Yield Better Result in Arterial Switch Operation: Comparison With Open Trap Door Technique

509

Coronary Reimplantatıon After Neoaortic Reconstruction in Arterial Switch Operation

510

Coronary Reimplantation During Jatene Procedure

511

Coronary reimplantation in aortic root replacement: a method to avoid tension

512

Coronary remodeling of proximal and distal stenotic atherosclerotic plaques within the same artery by intravascular ultrasound study

513

Coronary reoperation via small laparotomy using right gastroepiploic artery without CPB

514

Coronary reoperations: recurrence of angina and clinical outcome with and without cardiopulmonary bypass

515

Coronary reperfusion: numerators searching for denominators

516

Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

517

Coronary restenosis: a new strategy for the future?

518

Coronary restenosis: a review of mechanisms and management

519

Coronary Revascularization and Cardiac Catheterization in the United States: Trends in Racial Differences

520

Coronary revascularization and quality of life

521

Coronary Revascularization Before Noncardiac Vascular Surgery: One More Step Forward in Understanding Its Role

522

Coronary Revascularization for Patients With Diabetes: Updated Data Favor Coronary Artery Bypass Grafting

523

Coronary revascularization in older women and men in the United States: trends in ethnic differences

524

Coronary Revascularization in the Community: A Population-Based Study, 1990 to 2004 Original Research Article

525

Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction

526

Coronary revascularization is under-utilized in medicaid patients with acute myocardial infarction

527

Coronary revascularization of the circumflex

528

Coronary Revascularization Strategies in Patients With Diabetes and Multivessel Coronary Artery Disease: Has the Final Chapter Been Written?

529

Coronary Revascularization Strategy and Outcomes According to Blood Pressure (from the International Verapamil SR-Trandolapril Study [INVEST])

530

Coronary Revascularization Surgery After Myocardial Infarction: Impact of Bypass Surgery on Survival After Thrombolysis

531

Coronary revascularization with arterial conduits collateral to the lower limb

532

Coronary revascularization with or without cardiopulmonary bypass in patients with preoperative nondialysis-dependent renal insufficiency

533

Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future

534

Coronary revascularization without cardiopulmonary bypass in patients with pectus excavatum

535

Coronary Revascularization Without Cardiopulmonary Bypass Versus the Conventional Approach in High-Risk Patients

536

Coronary risk assessment in women

537

Coronary risk assessment in women

538

Coronary risk assessment methods and cholesterol lowering

539

Coronary risk assessment methods and cholesterol lowering

540

Coronary risk assessment methods and cholesterol lowering

541

Coronary risk assessment methods and cholesterol lowering

542

Coronary risk assessment methods and cholesterol lowering

543

Coronary risk assessment methods and cholesterol lowering

544

Coronary risk assessment methods and cholesterol lowering

545

Coronary risk factor status after percutaneous transluminal coronary angioplasty

546

Coronary risk factors and coronary atheroma burden at severely narrowing segments

547

Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants

548

Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) Original Research Article

549

Coronary risk factors in Indians

550

Coronary risk factors in patients with early-onset coronary disease and normal coronariography

551

Coronary risk factors in people from the Indian subcontinent

552

Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India

553

Coronary risk factors in women six months after coronary artery bypass grafting

554

Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: The muscatine study

555

Coronary risk reduction through intensive community-based lifestyle intervention: the Coronary Health Improvement Project (CHIP) experience

556

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis: The Heinz Nixdorf Recall Study

557

Coronary rotational ablation for calcific coronary artery stenosis in a young child

558

Coronary ruptured plaque mimicking spontaneous coronary dissection in a young woman

559

Coronary Segmental Responses to Acetylcholine and Bradykinin in Patients With Atherosclerotic Risk Factors

560

Coronary sinus adrenomedullin rises in response to myocardial injury

561

Coronary Sinus and Ascending Aortic Levels of Aldosterone, Angiotensin II, and B-Type Natriuretic Peptide in Patients With Aortic Stenosis and in Patients With Coronary Heart Disease

562

Coronary sinus catheterization via a femoral vein

563

Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure

564

Coronary sinus diverticulum as a cause of resistant posteroseptal pathway ablation

565

Coronary sinus interventions in cardiac surgery, 2nd edition: Edited by Werner Mohl, MD, PhD, Georgetown, Texas, Landes Bioscience, 2000, 224 pp, illustrated, $99.00, ISBN: 1-58706-006-X

566

Coronary Sinus Orifice Atresia With Left Superior Vena Cava in Patients With Univentricular Heart

567

Coronary sinus ostial atresia with persistent left superior vena cava

568

Coronary sinus ostial atresia: A rare associated anomaly that should be remembered in patients undergoing univentricular palliation

569

Coronary sinus pacing mistaken as interventricular septal perforation and subsequent left ventricular pacing by a transvenously introduced pacing electrode

570

Coronary Sinus Reducer Stent for the Treatment of Chronic Refractory Angina Pectoris: A Prospective, Open-Label, Multicenter, Safety Feasibility First-in-Man Study Original Research Article

571

Coronary Sinus Stenting for the Management of Left Ventricular Lead Displacement during Resynchronization Therapy: A Report of Two Cases

572

Coronary sinus thrombosis after cannulation during cardiopulmonary bypass

573

Coronary Slow Flow Phenomenon Clinical Findings and Predictors

574

Coronary slow flow: Benign or ominous?

575

Coronary Slow-Flow Phenomenon or Syndrome Y: A Microvascular Angina Awaiting Recognition

576

Coronary spasm after injection of ondansetron: Case report and review of the literature

577

Coronary spasm and hypersensitivity to amoxicillin: Kounis or not Kounis syndrome?

578

Coronary Stenosis Detection by 16-Slice Computed Tomography in Heart Transplant Patients: Comparison With Conventional Angiography and Impact on Clinical Management Original Research Article

579

Coronary stenosis dilatation induced by L-arginine

580

581

Coronary stent assessment on multidetector computed tomography: Source and predictors of image distortion

582

Coronary Stent Design and New Clinical Trial Insights

583

Coronary Stent Fracture and In-Stent Restenosis at Coronary Computed Tomography

584

Coronary stent fracture and restenosis in the drug-eluting stent era: Do we have clues of management?

585

Coronary stent fracture in a saphenous vein graft to right coronary artery — Successful treatment by the novel use of the Jomed coronary stent graft: Case report and review of the literature

586

Coronary stent grafts covered by a polytetrafluoroethylene membrane

587

Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution

588

Coronary stent implantation in acute myocardial infarction,

589

Coronary stent implantation in patients older than 75 years of age: Clinical profile and initial and long-term (3 years) outcome

590

Coronary stent implantation is superior to balloon angioplasty for chronic coronary occlusions: Six-year clinical follow-up of the GISSOC trial

591

Coronary stent implantation may seal the inflammatory response in patients with acute coronary syndromes

592

Coronary stent occlusion following strenuous exertion: is the risk actual? Is it preventable?

593

Coronary stent occlusion: Thrombus horribilis

594

Coronary Stent Placement in Patients With Acute Myocardial Infarction: Comparison of Clinical and Angiographic Outcome After Randomization to Antiplatelet or Anticoagulant Therapy

595

Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

596

Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial

597

Coronary stenting after rotational atherectomy in diffuse lesions of the small coronary artery: comparison with balloon angioplasty prior to stenting

598

Coronary stenting after unsuccessful emergency angioplasty in acute myocardial infarction: Results in a series of consecutive patients

599

Coronary Stenting and Inflammation

600

Coronary Stenting and Inflammation: Implications for Further Surgical and Medical Treatment

601

Coronary stenting and use of abciximab

602

Coronary stenting during acute myocardial infarction. Results from the stent without coumadin French registry

603

Coronary stenting for transplant coronary artery disease

604

Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts

605

Coronary stenting in cardiac allograft vasculopathy

606

Coronary stenting in diabetic patients: Results from the ROSETTA registry

607

Coronary stenting in patients undergoing percutaneous transluminal coronary angioplasty during acute myocardial infarction

608

Coronary stenting in the setting of spontaneous coronary artery dissection

609

Coronary stenting of bifurcation lesions using “T” or “reverse Y” configuration with Wiktor stent

610

Coronary stenting of unprotected left main stem stenoses in elderly patients unsuitable for coronary surgery

611

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting

612

Coronary stenting or percutaneous transluminal coronary angioplasty prior to noncardiac surgery increases adverse perioperative cardiac events: the evidence is mounting: Reply

613

Coronary stenting versus balloon angioplasty for acute myocardial infarction: A meta-regression analysis of randomized trials

614

Coronary stenting versus balloon angioplasty in small vessels

615

Coronary stenting versus balloon angioplasty in small vessels: A meta-analysis from 11 randomized studies Original Research Article

616

Coronary stenting with novel stainless steel balloon-expandable stent: Determinants of neointimal formation and changes in arterial geometry after placement in an atherosclerotic model

617

Coronary stenting with angioscopic guidance

618

Coronary stenting with AVE microstents in acute myocardial infarction

619

Coronary stents: A health system perspective, ,

620

Coronary stents: A materials perspective

621

Coronary stents: An industry perspective, ,

622

Coronary stents—open choices for closed arteries

623

Coronary subclavian steal: A recurrent case with notes on detecting the threat potential

624

Coronary Superficial and Spotty Calcium Deposits in Culprit Coronary Lesions of Acute Coronary Syndrome as Determined by Optical Coherence Tomography

625

Coronary surgery in patients with peripheral vascular disease: effect of avoiding cardiopulmonary bypass

626

Coronary Surgery in Patients With Preexisting Chronic Atrial Fibrillation: Early and Midterm Clinical Outcome

627

Coronary surgery with intermittent aortic cross-clamping: a word of caution on the incidence of cerebrovascular accidents: letter 2

628

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response

629

Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis Original Research Article

630

Coronary thrombosis

631

Coronary thrombosis associated with inherited protein S deficiency: A case report

632

Coronary Thrombosis From Large, Nonprotruding, Superficial Calcified Coronary Plaques

633

Coronary Thrombosis without Dissection following Blunt Trauma

634

Coronary to pulmonary artery collaterals in patients with pulmonary atresia and ventricular septal defect

635

Coronary to pulmonary artery fistula detected by transthoracic echocardiography

636

Coronary tracheal collaterals after heart–lung transplant

637

Coronary vascular dysfunction in premenopausal women with diabetes mellitus

638

Coronary Vascular Morphology in Pressure-overload Left Ventricular Hypertrophy

639

Coronary vascular reactivity is abnormal in patients with Chagasʹ heart disease

640

Coronary Vascular Remodeling in Association With Endothelial Dysfunction

641

Coronary vascular reserve is similarly reduced in hypertensive patients without any other coronary risk factors and in normotensive smokers and hypercholesterolemic patients with angiographically normal coronary arteries

642

Coronary vascular responses to short-term cocaine administration in conscious baboons compared with dogs

643

Coronary Vascular Responsiveness to Adenosine Is Impaired Additively by Blockade of Nitric Oxide Synthesis and Sulfonylure

644

Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism

645

Coronary vasoconstriction induced by mental stress (simulated public speaking)

646

Coronary Vasoconstrictive Effects of Neuropeptide Y and Their Modulation by the ATP-Sensitive Potassium Channel in Anesthetized Dogs

647

Coronary vasodilation by noninvasive transcutaneous ultrasound: An in vivo canine study

648

Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction

649

Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction

650

Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats

651

Coronary vasodilatory capacity and flow reserve are attenuated in normal myocardium supplied by bypass grafts

652

Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery

653

Coronary vasomotility and myocardial blood flow early after heart transplantation

654

Coronary Vasomotion After Percutaneous Transluminal Coronary Angioplasty Depends on the Severity of the Culprit Lesion

655

Coronary vasomotion and exercise‑induced adaptations in coronary artery disease patients: A systematic review and meta‑analysis

656

Coronary vasomotion during dynamic exercise: Influence of intravenous and intracoronary nicardipine

657

Coronary vasomotor function in a normotensive, nondiabetic referral population with normal coronary arteriograms

658

Coronary vasomotor reactivity among normotensive african and white american subjects with chest pain

659

Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration

660

Coronary Vasospasm and Coronary Atherosclerosis: Do We Have to Choose?

661

Coronary vasospasm and raspberry ketones weight-loss supplement: Is there a connection?

662

Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil

663

Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease

664

Coronary vasospasm due to hypercholinergic crisis: An example of normal coronary arteriogram and myocardial infarction

665

Coronary vasospasm during an adenosine stress test

666

Coronary vasospasm in a patient suffering from sarin poisoning

667

Coronary Vasospasm Induced During Isoproterenol Head-Up Tilt Test

668

Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis

669

Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease

670

Coronary vein balloon angioplasty forleft ventricular pacemaker lead implantation

671

Coronary venous angioplasty to a ring- like stricture preventing left ventricular lead insertion

672

Coronary venous imaging with electron beam computed tomographic angiography: Three-dimensional mapping and relationship with coronary arteries

673

Coronary ventricular fistula as a complication of PTCA: A case report and literature review

674

Coronary vessel trees from 3D imagery: A topological approach

675

Coronary wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations

676

Coronary-artery bypass surgery and the brain: persisting concerns

677

Coronary-Artery Stent

678

Coronary-Cameral Fistula Connecting the Left Anterior Descending Artery and the First Obtuse Marginal Artery to the Left Ventricle: A Rare Finding

679

Coronary-cameral fistula in an asymptomatic adult patient

680

Coronary-coronary bypass using the radial artery

681

Coronary-coronary radial artery graft for single, distal LAD lesion

682

Coronary-pulmonary artery fistula: Heart-on-a-heart appearance

683

Coronary-pulmonary fistula serving as a collateral source to the occluded coronary artery in a patient with myocardial infarction

684

Coronary-pulmonary steal syndrome

685

Coronary-Subclavian Steal Syndrome Following CABG: a Case Report and Literature Review

686

Coronary-subclavian steal syndrome in a hemodialysis patient with ipsilateral subclavian artery occlusion and contralateral vertebral artery stenosis “Case Report”

687

Coronary–Subclavian Steal Syndrome: An usual cause of refractory unstable angina

688

Coronary-to-coronary bypass using a free internal mammary artery: An alternative

689

Coronas and iridescence in mountain wave clouds

690

Coronas of balleans

691

CORONAS-F observations of active phenomena on the sun Original Research Article

692

CORONAS-F satellite: Tasks for study of particle acceleration Original Research Article

693

Coronatine alleviates salinity stress in cotton by improving the antioxidative defense system and radical-scavenging activity

694

Coronatine, a more powerful elicitor for inducing taxane biosynthesis in Taxus media cell cultures than methyl jasmonate

695

Coronavirus (COVID-19) and Possibilities for Criminal Law Reaction in Europe: A Review

696

Coronavirus (COVID-19) Infection in Newborns

697

Coronavirus (SARS-CoV-2) Deactivation via Spike Glycoprotein Shielding by Old Drugs: Molecular Docking Approach

698

Coronavirus and Divine Justice and its Relation to the Issue of Natural and Moral Evil

699

Coronavirus and Emergence of an Extraordinary Political Economy: editorial note

700

Coronavirus Anxiety: The Predictive Role of Perfectionism and Self-compassion

701

Coronavirus as a possible cause of severe acute respiratory syndrome

702

Coronavirus confirmed as cause of SARS

703

Coronavirus COVID-19 and its Effect on Erection and Patients’ Sexual Disorders: A Narrative Review

704

Coronavirus Disease (COVID-19) and Dental Treatment

705

Coronavirus Disease (COVID-19): 10 Questions and Discussion Points for Diabetes and COVID-19

706

Coronavirus Disease 19 with Spontaneous Pneumomediastinum: A Report of Three Cases

707

Coronavirus disease 2019 (COVID-19) and cardiovascular events

708

Coronavirus disease 2019 (COVID-19) and pediatric gastroenterology

709

Coronavirus Disease 2019 (COVID-19) in adolescents: An update on current clinical and diagnostic characteristics

710

Coronavirus Disease 2019 (Covid-19) in Middle East: Data, Facts and Doubts

711

Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series

712

Coronavirus Disease 2019 (COVID-19) Outbreak in Pediatrics and the Role of Pediatricians: A Systematic Review

713

Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission

714

Coronavirus Disease 2019 (COVID-19): review study

715

Coronavirus Disease 2019- Challenges Today and Tomorrow in Orthodontic Practice: A Review

716

Coronavirus Disease 2019 in Children with Acute Respiratory Infection: A Study From Southeastern Iran

717

Coronavirus Disease 2019 in Patients with Thalassemia; Emerging Challenges

718

Coronavirus Disease 2019 Occupational Considerations for Surgeons: A Review Article

719

Coronavirus Disease 2019 Vaccine Hesitancy in the Kurdistan Region: A Cross-Sectional National Survey

720

Coronavirus disease 2019: Global Contamination and Global Cleanup

721

Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential

722

Coronavirus Disease in Cardiovascular Patients: Clinical Characteristics and Final Prognosis

723

Coronavirus Disease-19 (COVID-19) Presenting with Severe Acute Pancreatitis: A Case Report from Iran

724

Coronavirus Disease-2019 Infection in Neonates of an Infected Pregnant Mother with Triplets

725

Coronavirus in severe acute respiratory syndrome (SARS)

726

Coronavirus Incidence Rate Estimation from Social Media Data in Iran

727

Coronavirus infections in children: from SARS and MERS to COVID-19, a narrative review of epidemiological and clinical features

728

Coronavirus N Protein N-Terminal Domain (NTD) Specifically Binds the Transcriptional Regulatory Sequence (TRS) and Melts TRS-cTRS RNA Duplexes

729

Coronavirus Pandemic and Worries during Pregnancy; a Letter to Editor

730

Coronavirus phylogeny based on triplets of nucleic acids bases

731

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses

732

Coronavirus, Its Neurologic Manifestations, and Complications

733

Coronavirus: Bibliometric analysis of scientific publications from 1968 to 2020

734

Coronavirus: Discover the Structure of Global Knowledge, Hidden Patterns & Emerging Events

735

Coronavirus: Nursing Students’ Knowledge and Risk Perception of Clinical Practice during the Pandemic

736

Coronavirus: Where Has All the Health Economics Gone?

737

Coronaviruses and gastrointestinal symptoms: an old liaison for the new SARS-CoV-2

738

Coronaviruses Pathogens in Human in Third Millennium (SARS-CoV, MERS, COVID-19): A Review Article

739

Coronavirus-induced Anxiety among Pregnant Women

740

Coronavirus-nephropathy; renal involvement in COVID-19

741

Coronavirus-Related Opportunities for Promoting Occupational Health and Safety

742

Coroner autopsies originating from complaints to the police in a Nigerian Urban centre

743

Coroner Wakley: two remarkable eyewitness accounts

744

Coroners and public health

745

Coronilla juncea is both a nutritive fodder shrub and useful in the rehabilitation of abandoned Mediterranean marginal farmland

746

Coronin 1B Antagonizes Cortactin and Remodels Arp2/3-Containing Actin Branches in Lamellipodia

747

Coronin 1B Coordinates Arp2/3 Complex and Cofilin Activities at the Leading Edge

748

Coronin-1A Stabilizes F-Actin by Bridging Adjacent Actin Protomers and Stapling Opposite Strands of the Actin Filament

749

Coronoid systems with perfect matchings Original Research Article

750

Corono-radicular biological restoration of maxillary central incisors by direct method

751

Corosolic acid induces apoptosis through mitochondrial pathway and caspases activation in human cervix adenocarcinoma HeLa cells

752

Corosolic acid induces apoptotic cell death in human lung adenocarcinoma A549 cells in vitro

753

COROT: A minisat for pionnier science, asteroseismology and planets finding Original Research Article

754

CoRoT: Harvest of the exoplanet program

755

Co-rotation constructions of residuated semigroups

756

Corotation resonances and planetary formation

757

Co-rotational beam elements with warping effects in instability problems Original Research Article

758

Co-rotational dynamic analysis of flexible beams Original Research Article

759

Co-rotational finite element formulation for thin-walled beams with generic open section Original Research Article

760

Co-rotational flat facet triangular elements for shell instability analyses Original Research Article

761

Co-rotational formulation for geometric nonlinear analysis of doubly symmetric thin-walled beams Original Research Article

762

Corotational formulation for nonlinear dynamics of beams with arbitrary thin-walled open cross-sections

763

Corotational mixed finite element formulation for thin-walled beams with generic cross-section

764

Corotational non-linear analysis of thin plates and shells using a new shell element

765

Corotational nonlinear dynamic analysis of laminated composite shells

766

CORPORA AMYLACEA IN HUMAN CADAVERIC BRAIN AGE RELATED DIFFERENCES

767

CORPORA IN LANGUAGE RESEARCH IN MALAYSIA

768

Corpora Lutea Diameter, Plasma Progesterone Concentration and Follicular Development in PGF2α and CIDR Estrus Synchronized Goats

769

CORPORA USE IN THE TEACHING OF ENGLISH WRITING

770

Corporal punishment and child adjustment

771

Corporal Punishment and its Effects in Pakistan

772

Corporal punishment and physical maltreatment against children: A community study on Chinese parents in Hong Kong

773

Corporal punishment and primary prevention of physical abuse

774

Corporate "central nervous system" software

775

Corporate and Institutional Transparency for Economic Growth in Europe, Oxelheim Lars (Ed.). Elsevier, Amsterdam (2006) 444p, € 76.99, ISBN 0-08-044665-5.

776

Corporate and social performance links in the gaming industry

777

Corporate asset purchases and sales: Theory and evidence

778

Corporate bankruptcies and official bail-outs: A cost–benefit analysis

779

Corporate behavior and competitiveness: impact of environmental regulation on Chinese firms

780

CORPORATE BLOGS AS ACORPORATECOMMUNICATION STRATEGY

781

Corporate board attributes and bankruptcy

782

Corporate boards and regulation: The effect of the Sarbanes–Oxley Act and the exchange listing requirements on firm value

783

Corporate body name changes: Helping the user search efficiently and effectively

784

Corporate bond default risk: A 150-year perspective

785

Corporate bond liquidity and matrix pricing

786

Corporate bond liquidity before and after the onset of the subprime crisis

787

Corporate bond ratings changes and economic instability: Evidence from the Korean financial crisis

788

Corporate Call Policy for Nonconvertible Bonds

789

Corporate capital structure and the characteristics of suppliers and customers

790

Corporate capital structure in turbulent times: a case study of the US airline industry

791

Corporate capture and Coca-Cola

792

Corporate cash flow and stock price exposures to foreign exchange rate risk

793

Corporate cash holdings and CEO compensation incentives

794

Corporate cash holdings: An empirical investigation of UK companies

795

Corporate Champions: doing good more effectively

796

Corporate characteristics, governance attributes and the extent of voluntary disclosure in Bangladesh

797

Corporate citizenship and public relations: The importance and interactivity of social responsibility issues on corporate websites

798

Corporate citizenship and the employee/citizen solider

799

Corporate comets or typical trajectories?: Corporate dynamics in the 1990s

800

Corporate communications managers in large firms: new challenges

801

Corporate Community Involvement. The Definitive Guide to Maximizing Your Business’ Societal Engagement

802

Corporate contracting for health care

803

Corporate control and enterprise structure in the Canadian economy: 1972–1987

804

Corporate control and industry structure in global communications: an introduction

805

Corporate control and real investment in incomplete markets

806

Corporate control and the market for managerial labour: On the decision to go public

807

Corporate control, bank risk taking, and the health of the banking industry

808

Corporate control, expected underpricing, and the choice of issuance mechanism in unseasoned equity markets

809

Corporate cost of occupational accidents: an activity-based analysis

810

Corporate Credibility’s Role in Consumers’ Attitudes and Purchase Intentions When a High versus a Low Credibility Endorser Is Used in the Ad

811

Corporate credit risk modeling and the macroeconomy

812

CORPORATE CRIME ANNOUNCEMENT EFFECTS ON STOCK PERFORMANCE: AN EMPIRICAL STUDY IN MALAYSIA

813

corporate crime in indonesian criminal law system

814

Corporate Cultural Dimensions, Social Responsibility and Financial Performance

815

Corporate Culture and Commitment: Impact on Performance of International New Product Development Programs

816

Corporate culture and the bottom line

817

Corporate culture, absorptive capacity and IT success

818

Corporate culture, related chief executive officer traits, and the development of executive information systems

819

Corporate debt and output pricing in developing countries: Industry-level evidence from Turkey

820

Corporate Default Prediction among Tehran Stock Exchange’s Selected Industries

821

Corporate derivatives use and firm value: Evidence from Turkey

822

Corporate disclosure quality, earnings smoothing, and earningsʹ timeliness

823

Corporate disclosures made by Chinese listed companies

824

Corporate distress and lobbying: Evidence from the Stimulus Act

825

Corporate diversification and asymmetric information: evidence from stock market trading characteristics

826

Corporate diversification and efficiency of manufacturing firms listed in Bursa Malaysia

827

Corporate diversification and performance: evidence on production efficiency

828

Corporate diversification and shareholder value: a survey of recent literature

829

Corporate diversification strategies and capital structure

830

Corporate diversification, information asymmetry and firm performance: Evidence from Tehran Stock Exchange

831

Corporate Diversification, Value Maximization, and Organizational Capabilities

832

Corporate diversification: identifying new businesses systematically in the diversified firm

833

Corporate diversification’s effects on Efficiency and productivity: case study of Manufacturing firms listed in Bursa Malaysia

834

Corporate dynamic transparency: the new ICT-driven ethics?

835

Corporate earnings and the equity premium

836

Corporate elites as informants in qualitative international business research

837

Corporate enterprise: a new reality for hospitality organisations?

838

Corporate entrepreneurs and privatized firms in russia, ukraine, and belarus

839

Corporate entrepreneurship and financial performance: The case of management leveraged buyouts

840

Corporate entrepreneurship antecedents and performance in agricultural advisory services corporations in west of Iran

841

Corporate entrepreneurship in network organizations:: How subsidiary initiative drives internal market efficiency

842

Corporate Entrepreneurship in Training Institutions

843

Corporate entrepreneurship:: antidote or oxymoron?

844

Corporate environme ntal behavior research: informing environme ntal policy

845

Corporate environmental and resource management: In search of a new managerial paradigm

846

Corporate environmental disclosure, financial markets and the media: An international perspective

847

Corporate environmental disclosures: are they useful in determining environmental performance?

848

Corporate environmental disclosures: Competitive disclosure hypothesis using 1991 annual report data

849

Corporate Environmental Innovation (CEI): a government initiative to support corporate sustainability leadership

850

Corporate Environmental Management 2: Culture and Organisations : , Earthscan Publications Ltd (1997) 192 £15.95. Building to Last: The Challenge for Business Leaders, , Earthscan Publications Ltd (1997) 204 £15.95

851

Corporate environmental management and regulation of mining operations in the Cyclades, Greece

852

Corporate environmental market responsiveness: A model of individual and organizational drivers

853

Corporate environmental responsibility in the supply chain

854

Corporate environmental responsiveness in India: lessons from a developing country

855

Corporate environmental strategy: The avalanche of change since Bhopal : B.W. Piasecki (author) John Wiley & Sons, 1995, 180 pp, ISBN 0-471-10627-5, US$24.95

856

Corporate environmentalism: the construct and its measurement

857

CORPORATE EQUAL OPPORTUNITIES (NON-) DISCLOSURE

858

Corporate ergonomics programme at automobiles Peugeot-Sochaux

859

Corporate ergonomics programme at BCM Airdrie

860

Corporate ergonomics programme at Ford Motor Company

861

Corporate ergonomics programme at Scottish & Newcastle

862

Corporate ergonomics programme at Volvo Car Corporation

863

Corporate Excellence in the Year 2000 : L K T , Century (1996), 350 pp., £18.99

864

Corporate Farm Performance in Russia, 1991–1995: An Efficiency Analysis

865

Corporate finance and state enterprise reform in China

866

Corporate finance—Theory and practice

867

Corporate Financial Accounting and Reporting: by Tim Sutton, Financial Times/Prentice Hall, Harlow, Essex, England, 2000, xiii+754 pp

868

Corporate financial decision-makers’ perceptions of workplace safety

869

Corporate financial disclosure in emerging markets: Does economic development matter?

870

CORPORATE FINANCIAL MANAGEMENT: TIME TO CHANGE THE “COST OF CAPITAL” PARADIGM?

871

Corporate Financial Reporting. Theory and Practice: Andrew Higson (Ed.); Sage, 2003, 228 pages, ISBN 0-7619-7141-6 (£24.99)

872

Corporate Financial Reporting: A Global Perspective: by Hervé Stolowy and Michel J. Lebas, Thomson, London, UK, 2002, xxvi+636 pp. ISBN: 1-861-52753-5, £31.99

873

Corporate Financial Reporting: By Bhabatosh Banerjee and Arun Kumar Basu (Eds.), University of Calcutta, Calcutta, 2001, vi+275 pages

874

Corporate Financial Strategies for Global Competitiveness

875

Corporate Financing and Goverance in Japan: The Road to the Future: by Takeo Hoshi and Anil Kashyap, MIT Press, 2002.

876

Corporate financing decisions when investors take the path of least resistance

877

Corporate financing decisions, managerial market timing, and real investment

878

Corporate firms in the 21st century: A note.

879

Corporate focus and stock returns,

880

Corporate focus and value creation evidence from spinoffs

881

Corporate focus versus diversification: the role of growth opportunities and cashflow

882

Corporate fraud, systematic risk, and shareholder enrichment

883

Corporate futures: social responsibility in the tourism industry: Angela Kalisch; Tourism Concern, London, 2002, 47pp, price £15 (£10 for members), ISBN 0-9528567-7-8

884

Corporate goodness and shareholder wealth

885

CORPORATE GOVERNANCE AND ACCOUNTING MODELS OF THE REPORTING ENTITY,

886

Corporate governance and accounting systems: a critical perspective

887

Corporate Governance and Audit Fees: Evidence from a Developing Country

888

Corporate Governance and Audit Opinion Shopping: Evidence from Iran

889

Corporate governance and audit report lag in Malaysia

890

Corporate governance and bank performance: A joint analysis of the static, selection, and dynamic effects of domestic, foreign, and state ownership

891

Corporate governance and board effectiveness

892

Corporate Governance and Corporate Social Responsibility: The Case of Small, Medium, and Large Firms

893

Corporate Governance and Credit Risk in the Iranian Banking Industry

894

Corporate governance and dividend pay-out policy in Germany

895

Corporate governance and dividend policy in emerging markets

896

Corporate governance and dividend policy: A comparison of Chinese firms listed in Hong Kong and in the Mainland

897

Corporate governance and earnings management in the Chinese listed companies: A tunneling perspective

898

Corporate Governance and Employee Ownership in an Economic Crisis: Enterprise Strategies in the Former USSR

899

Corporate governance and executive compensation

900

Corporate governance and firm cash holdings in the US

901

Corporate governance and firm performance: Evidence from Japanese manufacturing industries after the lost decade

902

Corporate governance and firm profitability: evidence from Korea before the economic crisis

903

Corporate governance and firm valuation

904

Corporate governance and firm value: evidence from the Korean financial crisis

905

Corporate governance and firm value\In Japan: Evidence from 1985 to 199

906

Corporate governance and globalization. Long range planning issues: Stephen S. Cohen & Gavin Boyd (Eds); Edward Elgar Publishing, Cheltenham, UK, 2000, pp. 373

907

Corporate governance and information asymmetry

908

Corporate governance and innovation: The UK compared with the US and ‘insider’ economies

909

CORPORATE GOVERNANCE AND INSTITUTIONAL INVESTORS: EVIDENCE FROM MALAYSIA

910

Corporate governance and intellectual capital

911

Corporate Governance and Investment Decisions in Deposit Money Banks in Nigeria

912

Corporate governance and investment in Central and Eastern Europe

913

Corporate governance and investment in East Asian firms—empirical analysis of family-controlled firms

914

Corporate Governance and Iranian Banking Economic Value Added

915

Corporate Governance and Liquidity Creation: Evidence from Iranian Banks

916

Corporate Governance and Liquidity Management: Evidence from Nigerian Deposit Money Banks

917

Corporate governance and lobbying strategies

918

Corporate governance and manager turnover: An unusual social experiment

919

Corporate governance and market valuation in China

920

Corporate governance and market valuation of capital and R&D investments

921

Corporate governance and mass privatisation: A theoretical investigation of transformations in legal and economic relationships

922

Corporate governance and merger performance: Learning from the Australian experience

923

Corporate governance and ownership structure of target companies and the outcome of takeovers

924

Corporate governance and pay-for-performance: The impact of earnings management

925

Corporate governance and performance of small high-tech firms in Sweden

926

Corporate governance and profit manipulation: a French field study

927

CORPORATE GOVERNANCE an‎d PUBLIC RELATIONS: A QUALITATIVE RESEARCH WITH PUBLIC RELATIONS EXPERTS

928

Corporate Governance and R D Reporting in Malaysian MESDAQ Market

929

Corporate governance and recent consolidation in the banking industry

930

CORPORATE GOVERNANCE AND ROLE OF CEO IN ENGINEERING COMPANIES

931

Corporate governance and shareholder initiatives: Empirical evidence

932

Corporate governance and shareholder patience

933

Corporate governance and state-owned shares in China listed companies

934

Corporate governance and the quality of financial analysts’ information

935

Corporate governance and the spinoff decision

936

Corporate governance and the value of cash holdings

937

Corporate governance and voluntary disclosure

938

Corporate Governance and Voluntary Disclosure Practices: Evidence from a Two Tier Board Systems in Indonesia

939

Corporate governance assessment in company board structure

940

Corporate governance attributes, firm characteristics and the level of corporate disclosure: Evidence from the Indian listed firms

941

Corporate Governance Characteristics and Company Performance

942

Corporate Governance Characteristics and Discretionary Accruals Among Non-Financial Firms Listed in Nairobi Securities Exchange

943

Corporate governance digest

944

Corporate governance effectiveness during institutional transitio

945

Corporate governance in China: An overview

946

Corporate governance in china: Explosive growth and new patterns of ownership

947

Corporate Governance in Insurance Sector and The Impact of Corporate Governance Committee

948

Corporate Governance in Russia:: towards a European, US, or Russian Model?

949

Corporate governance in South Korea: the chaebol experience

950

Corporate governance in the Asian countries

951

Corporate governance in the Asian financial crisis

952

CORPORATE GOVERNANCE IN THE CONTEXT OF CORPORATE SUSTAINABILITY: THE BIRTH, THE DEVELOPMENT an‎d THE EVALUATION OF THE CONCEPT

953

Corporate governance in the deregulated telecommunications industry: lessons from the airline industry

954

Corporate Governance in the Former Soviet Union

955

Corporate Governance in the Former Soviet Union: An Overview

956

Corporate Governance In Turkey: An Overview

957

Corporate governance indices and firmsʹ market values: Time series evidence from Russia

958

Corporate governance issues and director compensation structure in Spanish companies

959

Corporate Governance Mechanisms and Financial Performance: Evidence from the Listed Bank in Bangladesh

960

Corporate governance of Japanese banks

961

Corporate governance over the business cycle

962

Corporate Governance Perspectives for Zimbabwean SMEs

963

Corporate governance post-Enron: Effective reforms, or closing the stable door?

964

Corporate Governance Practices and Environmental Reporting of Companies in Malaysia: Finding Possibilities of Double Thumbs Up

965

Corporate Governance Practices in Bangladesh: A Comparative Analysis between Conventional Banks and Islamic Banks

966

Corporate governance practices, CEO characteristics and firm performance

967

Corporate governance proposals and shareholder activism: the role of institutional investors

968

Corporate governance provisions and firm ownership: Firm-level evidence from Eastern Europe

969

Corporate Governance Quality :A Literature Review

970

Corporate Governance Structure, Legal Environment, and Valuation

971

Corporate governance when founders are directors

972

Corporate Governance with the Institutional Theory Approach on Regional Development Banks in Indonesia

973

Corporate Governance, Accountability, and Pressures to Perform: An International Study: by Istemi S. Demirag, JAI Press, Stamford, CT, 1998, xv+395 pp.

974

Corporate governance, bank specific characteristics, banking industry characteristics, and Intellectual Capital (IC) performance of banks in Arab Gulf Cooperation Council (GCC) countries

975

Corporate governance, chief executive officer compensation, and firm performance

976

Corporate governance, competition policy and industrial policy

977

Corporate governance, corporate social responsibility and corporate risk: Evidence on Indonesia

978

Corporate governance, dividend payout policy, and the interrelation between dividends, R&D, and capital investment

979

Corporate Governance, Executive Directors and Level of Voluntary Disclosure: The Case of Public Listed Companies in Thailand

980

Corporate governance, investor protection, and performance in emerging markets

981

Corporate governance, ownership dispersion and efficiency: Empirical evidence from Austrian cooperative banking

982

Corporate governance, Sarbanes-Oxley, and small-cap firm performance

983

Corporate governance, shareholder rights and firm diversification: An empirical analysis

984

Corporate governance, strategic philanthropy, and public policy

985

Corporate governance, top executive compensation and firm performance\In Japan

986

Corporate governance, tourism growth and firm performance: Evidence from publicly listed tourism firms in five Middle Eastern countries

987

Corporate governance: Accountability, enterprise and international comparisons, 2005

988

Corporate Governance: Board Structure, Information Technology and CSR Reporting

989

CORPORATE GOVERNANCE: CAN CREDITORS FIT IN WITH COMPANIES’ BOARD OF DIRECTORS?

990

Corporate governance: Kenneth A. Kim, John R. Nofsinger; Pearson Education Inc., 94 pages, ISBN 0131423878, £19.99

991

CORPORATE GOVERNANCE: NOMINEE DIRECTOR THE GATEKEEPER

992

CORPORATE GOVERNANCE: OVERVIEW AND RESEARCH AGENDA

993

Corporate Governance: SMEs Experience in Metro Cebu, Philippines

994

Corporate Governance: Theory and Some Insights into the Malaysian Practices

995

Corporate governance\In New Zealand: The effect of the 1993 Companies Act on the relation between board composition and firm performance

996

Corporate government digest

997

Corporate groups, dual-class shares and the value of voting rights

998

Corporate Harm Minimisation: Promises and Perils; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019”

999

Corporate heritage identity management and the multi-modal implementation of a corporate heritage identity

1000

Corporate identity: The role of mission statements

بازگشت